The future of fMRI

Recent articles

This series of essays explores new developments and challenges in human brain imaging.

Get notified every time a new column in this series is published.

A hand holds multi-colored cubes.

Should we use the computational or the network approach to analyze functional brain-imaging data—why not both?

Emerging methods make it possible to combine the two tactics from opposite ends of the analytic spectrum, enabling scientists to have their cake and eat it too.

By Mac Shine
13 May 2024 | 7 min listen
Illustration of a hand reaching out to adjust a dial that sits in the middle of several images depicting brain activity and various behaviors.

To improve big data, we need small-scale human imaging studies

By insisting that every brain-behavior association study include hundreds or even thousands of participants, we risk stifling innovation. Smaller studies are essential to test new scanning paradigms.

By Emily S. Finn
15 April 2024 | 7 min read
An illustration of a mouse sitting in an armchair next to a framed picture of mouse brains

To make fMRI more clinically useful, we need to really get BOLD

A better understanding of the blood oxygen level dependent, or BOLD, signal requires more support for multimodal imaging studies.

By Evelyn Lake
22 January 2024 | 6 min read

Explore more from The Transmitter

Double-duty neurons in primary olfactory cortex pick up on more than just scent

The cells recognize not only odors, such as bananas and black licorice—but also images and words associated with those smells, according to single-neuron recordings from 17 people.

By Angie Voyles Askham
9 October 2024 | 7 min read

How neuroscience comics add KA-POW! to the field: Q&A with Kanaka Rajan

The artistic approach can help explain complex ideas frame by frame without diluting the science, Rajan says.

By Olivia Gieger
9 October 2024 | 7 min read

Former Columbia University psychiatrist committed research misconduct, says federal watchdog

Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.

By Brendan Borrell, Ellie Kincaid
8 October 2024 | 3 min read